Real-world evidence of the safety and efficacy profile of suvorexant (Belsomra®) in elderly patients with insomnia: a sub-analysis of the post-marketing drug-use results survey in Japan.

AbstractObjective: Global Phase III trials of suvorexant showed no obvious differences in the safety and efficacy profile of suvorexant between elderly and non-elderly patients. However, the clinic...